Saturday, April 07, 2012 10:54:49 AM
Investors vary widely in their risk tolerance depending on their belief's, abilities, expectations, economic situations etc.
Obviously your risk tolerance is at the lower end of the scale, as shown by your insistence of concrete evidence.
What standard of evidence they require is precisely what distinguishes between the different risk tolerances of investors.
Investors such as yourself buy in later and experience less risk but also experience far smaller gains.
What works best for any individual largely depends on their ability to evaluate companies at varying levels of evidence.
Obviously, from what you've said, it is quite a bit early for someone with your risk tolerance to be establishing a position in KBLB. However following a company for a period before investing can be an excellent approach: if and when you do invest you will understand it better. The risk of that approach is arriving at the decision to establish a position at the worst possible time: i.e.: immediately after big news and in the middle of a sharp spike. (Such spikes generally retrace a considerable percentage so it's easy to get "trapped" in a loss position for a considerable period of time.
My suggestion is that you be careful that, if and when you decide to invest in the company, do NOT do so during a sharp spike following a major news event (or preceding one). Wait for the SP to retrace and consolidate. (A bit of DD on charting will tell you signs to watch for.) And "averaging in" investing fixed amounts at fixed time intervals is another approach that reduces the risk of being trapped by a spike: you won't get the best price that way but you will avoid the worst.
It is best to invest in companies (and at times) that fit your risk tolerance. Exceeding your tolerance can lead to impulsive decisions at the worst possible times.
Obviously your risk tolerance is at the lower end of the scale, as shown by your insistence of concrete evidence.
What standard of evidence they require is precisely what distinguishes between the different risk tolerances of investors.
Investors such as yourself buy in later and experience less risk but also experience far smaller gains.
What works best for any individual largely depends on their ability to evaluate companies at varying levels of evidence.
Obviously, from what you've said, it is quite a bit early for someone with your risk tolerance to be establishing a position in KBLB. However following a company for a period before investing can be an excellent approach: if and when you do invest you will understand it better. The risk of that approach is arriving at the decision to establish a position at the worst possible time: i.e.: immediately after big news and in the middle of a sharp spike. (Such spikes generally retrace a considerable percentage so it's easy to get "trapped" in a loss position for a considerable period of time.
My suggestion is that you be careful that, if and when you decide to invest in the company, do NOT do so during a sharp spike following a major news event (or preceding one). Wait for the SP to retrace and consolidate. (A bit of DD on charting will tell you signs to watch for.) And "averaging in" investing fixed amounts at fixed time intervals is another approach that reduces the risk of being trapped by a spike: you won't get the best price that way but you will avoid the worst.
It is best to invest in companies (and at times) that fit your risk tolerance. Exceeding your tolerance can lead to impulsive decisions at the worst possible times.
Recent KBLB News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/21/2026 06:41:52 PM
- Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons • GlobeNewswire Inc. • 04/20/2026 11:05:00 AM
- The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future • GlobeNewswire Inc. • 04/15/2026 01:15:00 PM
- Advanced Materials Science 2026: How Spider Silk, Carbon Fiber & Aerogels are Powering Medicine, Defense & Space Tech Today • GlobeNewswire Inc. • 04/14/2026 01:20:00 PM
- From Milestone to Momentum: Kraig Biocraft Leadership Travels to South East Asia Following Record-Setting 1.3 Metric Ton Recombinant Spider Silk Cocoon Production Cycle • GlobeNewswire Inc. • 04/13/2026 11:05:00 AM
- From Genetic Puzzle to Industrial Platform • GlobeNewswire Inc. • 04/08/2026 01:31:34 PM
- Why Advanced Materials Are Reshaping the Industrial Ecosystem • GlobeNewswire Inc. • 04/07/2026 01:15:00 PM
- The intersection of biotechnology, advanced materials, and molecular biology • IH Market News • 04/07/2026 06:56:44 AM
- Spider Silk Has Been a Lab Curiosity for Decades; One Company Just Produced Over a Ton of It in a Single Month • AllPennyStocks.com • 04/06/2026 05:06:15 PM
- Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High • GlobeNewswire Inc. • 04/06/2026 11:05:00 AM
- From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk • GlobeNewswire Inc. • 04/02/2026 01:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:38:14 PM
- Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan • GlobeNewswire Inc. • 03/30/2026 11:05:00 AM
- Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics • GlobeNewswire Inc. • 03/23/2026 11:05:00 AM
- Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commercial Scale • GlobeNewswire Inc. • 03/18/2026 12:51:04 PM
- 24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making • GlobeNewswire Inc. • 03/11/2026 01:15:00 PM
- Washington’s Textile Strategy: How DPA Title III Could Strengthen U.S. Manufacturing and Defense Supply Chains • GlobeNewswire Inc. • 03/05/2026 03:05:00 PM
- Kraig Biocraft Laboratories Targets New Industrial and Defense Biomaterials as "Project Atlas" Hits Major Milestone • GlobeNewswire Inc. • 03/05/2026 12:05:00 PM
- Defense Supply Chains and Strategic Materials Drive the Morning Bid • GlobeNewswire Inc. • 03/03/2026 02:51:45 PM
- Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength • GlobeNewswire Inc. • 02/27/2026 02:45:46 PM
- Biotech and Big Tech Drive the Morning Narrative • GlobeNewswire Inc. • 02/24/2026 03:17:14 PM
- 24/7 Market News- “Somewhere in Michigan”: National Geographic Spotlights Kraig Biocraft Laboratories Science Powering Recombinant Spider Silk Production • GlobeNewswire Inc. • 02/24/2026 01:05:00 PM
- Biotech Breakthroughs, Big Buyouts, Immunotherapy Momentum, and a Media Megamerger • GlobeNewswire Inc. • 02/23/2026 02:36:14 PM
- Kraig Biocraft Laboratories’ Spider Silk Advancements Featured as the Cover of National Geographic's March 2026 Issue • GlobeNewswire Inc. • 02/23/2026 12:05:00 PM
- $30M Revenue Rocket, Super Spiders, and Biotech Patent Blitz Launch Morning Momentum • GlobeNewswire Inc. • 02/19/2026 04:00:26 PM
